摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

6,7-二羟基-3-(4-甲氧基苯基)色满-4-酮 | 76397-85-8

中文名称
6,7-二羟基-3-(4-甲氧基苯基)色满-4-酮
中文别名
——
英文名称
2,3-Dihydro-6,7-dihydroxy-3-(4-methoxyphenyl)-4H-1-benzopyran-4-one
英文别名
6,7-dihydroxy-3-(4-methoxyphenyl)-2,3-dihydrochromen-4-one
6,7-二羟基-3-(4-甲氧基苯基)色满-4-酮化学式
CAS
76397-85-8
化学式
C16H14O5
mdl
——
分子量
286.284
InChiKey
PZSNGTWDLWGBMP-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.3
  • 重原子数:
    21
  • 可旋转键数:
    2
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.19
  • 拓扑面积:
    76
  • 氢给体数:
    2
  • 氢受体数:
    5

安全信息

  • 海关编码:
    2932999099

反应信息

  • 作为产物:
    描述:
    6,7-二羟基-4-甲氧基异黄酮 在 palladium on activated charcoal 氢气 作用下, 以 1,4-二氧六环乙醇 为溶剂, 反应 6.0h, 以52%的产率得到6,7-二羟基-3-(4-甲氧基苯基)色满-4-酮
    参考文献:
    名称:
    Structure–activity relationship studies of flavonoids as potent inhibitors of human platelet 12-hLO, reticulocyte 15-hLO-1, and prostate epithelial 15-hLO-2
    摘要:
    Human lipoxygenase (hLO) isozymes have been implicated in a number of disease states and have attracted much attention with respect to their inhibition. One class of inhibitors, the flavonoids, have been shown to be potent lipoxygenase inhibitors but their study has been restricted to those compounds found in nature, which have limited structural variability. We have therefore carried out a comprehensive study to determine the structural requirements for flavonoid potency and selectivity against platelet 12-hLO, reticulocyte 15-hLO-1, and prostate epithelial 15-hLO-2. We conclude from this study that catechols are essential for high potency, that isoflavones and isoflavanones tend to select against 12-hLO, that isoflavans tend to select against 15-hLO-1, but few flavonoids target 15-hLO-2. (C) 2007 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2007.07.036
点击查看最新优质反应信息

文献信息

  • COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS
    申请人:Miller Freda
    公开号:US20110301105A1
    公开(公告)日:2011-12-08
    We have discovered that p63 inhibition results in increased cellular proliferation. We have also performed a screen for agents capable of increasing cellular proliferation, (e.g., of stem cells such as skin-derived precursors (SKPs)). The invention therefore invention provides compositions, methods, and kits for increasing proliferation of cells, using compounds that decrease p63 expression or activity or using the compounds described herein. The invention also features methods of using these compounds for increasing hair growth, improving skin health, or promoting skin repair in a subject.
  • US8748177B2
    申请人:——
    公开号:US8748177B2
    公开(公告)日:2014-06-10
  • [EN] COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS<br/>[FR] COMPOSITIONS POUR LA PROLIFÉRATION DE CELLULES ET PROCÉDÉS ASSOCIÉS
    申请人:HOSPITAL FOR SICK CHILDREN
    公开号:WO2010039679A1
    公开(公告)日:2010-04-08
    We have discovered that p63 inhibition results in increased cellular proliferation. We have also performed a screen for agents capable of increasing cellular proliferation, (e.g., of stem cells such as skin-derived precursors (SKPs)). The invention therefore invention provides compositions, methods, and kits for increasing proliferation of cells, using compounds that decrease p63 expression or activity or using the compounds described herein. The invention also features methods of using these compounds for increasing hair growth, improving skin health, or promoting skin repair in a subject.
  • Structure–activity relationship studies of flavonoids as potent inhibitors of human platelet 12-hLO, reticulocyte 15-hLO-1, and prostate epithelial 15-hLO-2
    作者:Yesseny Vasquez-Martinez、Rachana V. Ohri、Victor Kenyon、Theodore R. Holman、Silvia Sepúlveda-Boza
    DOI:10.1016/j.bmc.2007.07.036
    日期:2007.12
    Human lipoxygenase (hLO) isozymes have been implicated in a number of disease states and have attracted much attention with respect to their inhibition. One class of inhibitors, the flavonoids, have been shown to be potent lipoxygenase inhibitors but their study has been restricted to those compounds found in nature, which have limited structural variability. We have therefore carried out a comprehensive study to determine the structural requirements for flavonoid potency and selectivity against platelet 12-hLO, reticulocyte 15-hLO-1, and prostate epithelial 15-hLO-2. We conclude from this study that catechols are essential for high potency, that isoflavones and isoflavanones tend to select against 12-hLO, that isoflavans tend to select against 15-hLO-1, but few flavonoids target 15-hLO-2. (C) 2007 Elsevier Ltd. All rights reserved.
查看更多